Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease
Abstract Hyperphosphatemia is present in most patients with end‐stage renal disease (ESRD) and has been associated with increased cardiovascular mortality. Phosphate binders (calcium‐based and calcium free) are the mainstay pharmacologic treatment to lower phosphorus levels in patients with ESRD. We...
Saved in:
Main Authors: | Darius L. Mason (Author), Kavitha Godugu (Author), Daryl Nnani (Author), Shaker A. Mousa (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different Effect of Lanthanum Carbonate and Sevelamer Hydrochloride on Calcium Balance in Patients with Moderate to Advanced Chronic Kidney Disease
by: Makowka A, et al.
Published: (2021) -
Sevelamer hydrochloride and coronary artery calcification in chronic hemodialysis patients: a new mechanism of action
by: Bahaa Eldin Zayed, et al.
Published: (2015) -
Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
by: Vincenzo Savica, et al.
Published: (2008) -
Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemia
by: Rosamund J Wilson, et al.
Published: (2017) -
Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease-A Comparative Clinical Study
by: Parminder Nain, et al.
Published: (2023)